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X-Ray Fiber Diffraction Reveals Major Structural Differences Between
Brain-Derived Prions and Recombinant Prion Protein Amyloid
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X-ray fiber diffraction was used to study the structure of brain-derived prions
and recombinant prion protein amyloid. Partially oriented, dried fibers were
prepared from brain-derived PrP 27-30 and recombinant PrP amyloid. Fiber
diffraction patterns were analyzed and used to interrogate models for the struc-
ture of the infectious prion.
Fiber diffraction patterns of recombinant PrP amyloid displayed characteristic,
meridional reflections at ~4.8 A˚ and equatorial reflections at ~10 A˚. These pat-
terns were similar to those of other amyloids and are consistent with a basic
cross-b architecture. In contrast, diffraction patterns from brain-derived PrP
27-30 displayed meridional reflections at ~9.6, ~6.4, and ~4.8 A˚, which corre-
spond to the 2nd, 3rd, and 4th order of a ~19.2-A˚ repeating unit, suggesting that
PrP 27-30 contains four b-strands in a cross-b architecture. Furthermore, PrP
27-30 lacked the typical, equatorial reflection at ~10 A˚, but instead produced
equatorial reflections characterizing the diameter of the amyloid fiber and of in-
dividual protofilaments. Therefore, PrP 27-30 seems to have a structure consis-
tent with a b-helix or b-solenoid, not unlike the model that was proposed earlier
(Govaerts et al., 2004). This interpretation was also supported by extensive
modeling, simulation of diffraction, electron microscopy, and FTIR.
In a previous study, recombinant PrP amyloid induced a transmissible prion
disease in transgenic mice overexpressing PrP, and was thus termed a "synthetic
prion" (Legname et al., 2004). Serially transmitted, synthetic prions were puri-
fied from mouse brains and analyzed by fiber diffraction. These brain-derived,
synthetic prions showed the same structural characteristics as natural prion iso-
lates and not those of its recombinant protein precursor. The relationship be-
tween structural differences and prion infectivity can be explained by several
hypotheses. It remains to be determined which one, if any, is correct.
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A feature of many neurodegenerative diseases is the rearrangement of a specific
protein to a non-native conformation, promoting aggregation, amyloid fibril
formation, and deposition within tissues or cellular compartments. Such dis-
eases include Alzheimer’s disease (AD), Parkinson’s disease (PD), and Hun-
tington’s disease (HD). Huntington’s disease (HD) is caused by an expansion
above 35-40 polyglutamine (polyQ) repeats in the huntingtin (htt) protein
and results in accumulation of inclusion bodies that contain fibrillar deposits
of mutant htt fragments. Intriguingly, polyQ length is directly proportional to
the propensity for htt to form fibrils and to the severity of HD, and is inversely
correlated to the age of onset. Although the structural basis for htt toxicity is
unclear, the formation, abundance and/or persistence of toxic conformers that
mediate neuronal dysfunction and degeneration in HD must also be polyQ
length-dependent. Here we used atomic force microscopy (AFM) to show
that mutant htt fragments and synthetic polyQ peptides form oligomers in
a polyQ length-dependent manner. Time-lapse AFM shows oligomers form be-
fore fibrils, are transient in nature, and are occasionally direct precursors to fi-
brils. However, the vast majority of fibrils appear to form by monomer addition
that coincides with the disappearance of oligomers. Thus, oligomers must un-
dergo a major structural transition that precedes fibril formation. These results
demonstrate that oligomer formation by a mutant htt fragment is strongly polyQ
length-dependent, consistent with a causative role for these structures in HD
pathogenesis.
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Alzheimer disease (AD) is a progressive neurodegenerative disease associated
with accumulation of aggregated Ab1-40/Ab1-42 peptides in the brain. Ordered
aggregates can extend into b-strand enriched fibrils, regardless of their initial
native conformational states. To date, the self-assembly mechanism leading
to ordered fibril formation is not fully understood. Understanding the mecha-nisms and the range of structural features of the aggregates are of crucial im-
portance for effective drug design to reduce aggregate formation. The polymor-
phism of Ab1-42 based on ssNMR, EM, 2D hydrogen exchange and mutational
studies, was investigated using all-atom molecular dynamics simulations with
explicit solvent. Open questions relate to (1) how the monomeric peptides as-
semble into oligomers; (2) which segments of a long peptide constitute the rec-
ognition motifs and as such playing key roles in amyloid fibril formation; (3)
how the b-strands arrange relative to one another; (3) is there a favored orga-
nization between the b-sheets and if so as one would expect (4) what is it and
what are the intermolecular interactions between the layers that stabilize the fa-
vored amyloid fibril organization(s) are discussed. This project has been funded
in whole or in part with Federal funds from the NCI, NIH, under contract num-
ber HHSN261200800001E.
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The oligomerization of amyloid b-protein (Ab) is a seminal event in the neu-
rodegenerative process in Alzheimer’s disease (AD). Ab40 and Ab42, the
two predominant forms of Ab, display different aggregation behavior which
underlies the special pathogenetic significance of Ab42. Previous computa-
tional studies have revealed that a turn-like structure exists at the C-terminal
of Ab42 that is not observed in Ab40. We report here results of studies to define
the structure of this turn and to establish its role in Ab assembly. We used mo-
lecular dynamics to simulate the structure of the Ab C-terminus (Gly31-Val40/
Ala42) and discovered that the dihedral angles of residues 36 and 37 tend to be
locked into a region of Ramachanran space consistent with type-II b-turns.
Ab(31-42) predominantly formed a b-hairpin-like structure that was stabilized
by hydrogen bonds and hydrophobic interactions between residues 31-35 and
residues 38-42. In contrast, Ab(31-40) appeared relatively unstructured. To in-
vestigate the possible role of this peptide-specific, b-hairpin-like structure in
Ab assembly, we synthesized a number of Ab "mutants" containing amino
acid substitutions that we postulated would stabilize or destabilize the hairpin.
The stabilizing substitutions facilitated hexamer and dodecamer formation by
Ab42, abolishing formation of fibrils. Interestingly, compared to wild type
Ab42, these substituted peptides were equally toxic. When these substitutions
were incorporated into Ab40, the modified Ab40 oligomerized like Ab42, in-
stead of an "Ab40-like" distribution. In addition, the modified Ab40 was signif-
icantly more toxic than wild type Ab40. Substitutions in Ab42 that were pre-
dicted to destabilize the turn abolished hexamer and dodecamer formation
and resulted in an Ab42 oligomer size distribution similar to that of Ab40.
Our experiments appear to define the structural determinant that "makes
Ab42 Ab42." If true, this structure would be an exceptionally important ther-
apeutic target.
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A Solid-State NMR Study Reveals Structure and Dynamics in Copper(ii)-
Binding to Alzheimer’s Beta-Amyloid Fibrils
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b-amyloid (Ab) peptide associated with Alzheimer’s diseases exhibit neural
toxicity upon aggregation. One of the most widespread hypotheses on the origin
of the toxicity of Ab aggregates is the binding of Cu2þ ions to Ab fibrils and
subsequent generation of reactive oxygen species (ROS) such as H2O2 by
Cu2þ-bound Ab. Although a variety of studies have been performed on
Cu2þ-binding to Ab, the proposed binding sites or models have been controver-
sial partly because non-crystalline and insoluble nature of Ab fibrils have lim-
ited access to site-specific structure and dynamic properties on Cu2þ-bound Ab
fibrils. Here, we examine the effect of Cu2þ binding to amyloid fibrils of 40-res-
idue Ab(1-40) by UV-VIS spectroscopy and solid-state NMR (SSNMR). Spe-
cifically, we will answer the following questions (i) Is the Cu2þ binding is site
specific? (ii) If so, which sites are involved in binding? (iii) Are there any major
structural changes introduced by Cu2þ binding or oxidization due to Cu2þ?
UV-VIS spectroscopy showed that Cu2þ binds to Ab(1-40) fibrils almost com-
pletely when the ratio of Cu2þ to Ab(1-40) is less than 1. Based on the result,
we performed high-resolution SSNMR experiments on Cu2þ-bound Ab(1-40)
fibrils. First, the 13C T1 paramagnetic relaxation enhancement (PRE) due to
Cu2þ binding on Ab was measured for different residues; the PRE data high-
light possible binding sites, where the relaxation enhancements are notable.
The analysis indicates that the binding is specific, and Cu2þ most likely binds
to His-13/14 and His-6. Second, the comparison of 2D 13C/13C correlation
spectra of Ab fibrils with and without Cu2þ revealed that the secondary struc-
ture of Ab(1-40) fibrils is largely unaltered by Cu2þ binding. Third, we tested
